25.03.2013 Views

Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...

Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...

Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Cost of major amputation<br />

The hospitalisation cost of AN-DRG 411 Amputation (21.5 days average length of stay)<br />

is $14,805. 121 In the absence of more precise data for a variety of causes, this DRG cost<br />

is used to approximate the cost of a major amputation. This cost is an average cost for all<br />

types of amputation and may not be an accurate cost for major amputations specifically<br />

associated with diabetes. More precise Australian patient level cost data could be used.<br />

However even these data may be an overestimate of the resources saved by reducing the<br />

number of amputations overall. In some of the studies of HBOT, patients were recruited<br />

from in-patients. In those studies there was some evidence of a reduced length of stay<br />

with HBOT but this was not significant. Attributing the full cost of a hospital stay<br />

involving an amputation (21.5 days in the national casemix data) as a saving with HBOT<br />

may be an overestimate for patients already admitted for a diabetic wound. No<br />

information on the change in resource use associated with a major amputation for<br />

patients admitted as a result of a diabetic wound is available. Such data could only come<br />

from a prospective randomised trial of HBOT in which resource use data were collected.<br />

Major amputations are also expected to incur rehabilitation costs, and these are expected<br />

to increase the costs associated with major amputations. The hospitalisation cost of AN-<br />

DRG 941 Rehabilitation (20 days average length of stay) is $8,758. 121 This may not be an<br />

accurate cost for rehabilitation associated with amputations given the extra cost of<br />

prostheses. However, in the absence of more precise data, this DRG cost is used to<br />

approximate the acute hospitalisation cost of rehabilitation for major amputations. The<br />

costs of rehabilitation after being discharged from hospital have not been included in the<br />

analysis in Tables 77and 78.<br />

An incremental cost-effectiveness analysis with and without cost offsets from<br />

amputations avoided is shown in Table 77.<br />

Table 77 Estimation of incremental cost per major amputation avoided – 100 patients<br />

100 patients Intervention Group Comparison Group Incremental<br />

(HBOT)<br />

(no HBOT)<br />

Incremental treatment costs of<br />

HBOT<br />

$694,105 - $694,105<br />

Major Amputations 20 avoided<br />

Incremental HBOT cost per<br />

amputation avoided<br />

Difference in cost of major<br />

amputation (cost savings)<br />

20 major amputations prevented<br />

$34,705<br />

($296,100)<br />

Difference in cost of<br />

($175,160)<br />

rehabilitation (cost savings)<br />

Net Cost $222,845<br />

Incremental cost per major<br />

$11,142<br />

amputation avoided<br />

There is an argument to limit the analysis to major amputations, on the grounds that only<br />

these were statistically significant in the pooled analysis. As shown in Table 77 if no cost<br />

offsets are considered, the incremental cost per major amputation avoided is estimated as<br />

$34,705. When the cost offsets of major amputations are considered, the incremental<br />

cost per major amputation avoided is $11,142. The analysis in Table 77 only uses the<br />

acute hospitalisation cost of major amputations and rehabilitation. If outpatient<br />

<strong>Hyperbaric</strong> oxygen therapy 83

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!